Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Clayton

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Journal of the American College of Cardiology|August 1, 2015
10-Year Mortality Outcome of a Routine Invasive Strategy Versus a Selective Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndrome: The British Heart Foundation RITA-3 Randomized TrialRobert A Henderson, Christopher Jarvis, Tim Clayton, et al.
European Journal of Cardiovascular Nursing|August 25, 2021
Wonder women: wondering where the women in cardiovascular trials are?Samantha Cook, Stacey Matthews, Sarah Murray, et al.
Journal of the American College of Cardiology|March 26, 2016
Reply: Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?Robert A Henderson, Chris Jarvis, Tim Clayton, et al.
Journal of the American College of Cardiology|February 6, 2016
Reply: Survival Differences in Clinical Trials With Long-Term Follow-upRobert A Henderson, Chris Jarvis, Tim Clayton, et al.
Science & Justice : Journal of the Forensic Science Society|March 19, 2021
An investigation of two methods of DNA recovery from fired and unfired 9 mm ammunitionDavid Moore, Dan Beaumont, Melanie Brown, et al.
Circulation|July 9, 2008
Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS)Jean Booth, Tim Clayton, John Pepper, et al.
Journal of the American College of Cardiology|October 22, 2013
Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)Gregg W Stone, Tim Clayton, Efthymios N Deliargyris, et al.
BMJ (Clinical Research Ed.)|August 19, 2014
Quantification of risk factors for herpes zoster: population based case-control studyHarriet J Forbes, Krishnan Bhaskaran, Sara L Thomas, et al.
Research Involvement and Engagement|March 9, 2021
Patient and public involvement prior to trial initiation: lessons learnt for rapid partnership in the COVID-19 eraZahra Jamal, Alexander Perkins, Christopher Allen, et al.
Therapeutic Innovation & Regulatory Science|February 26, 2025
The Data Monitoring Experience in Empagliflozin Randomized Clinical Trials Between 2011 and 2024Francine K Welty, Klaus G Parhofer, Marvin Konstam, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Journal of the American College of Cardiology|August 1, 2015
10-Year Mortality Outcome of a Routine Invasive Strategy Versus a Selective Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndrome: The British Heart Foundation RITA-3 Randomized TrialRobert A Henderson, Christopher Jarvis, Tim Clayton, et al.
European Journal of Cardiovascular Nursing|August 25, 2021
Wonder women: wondering where the women in cardiovascular trials are?Samantha Cook, Stacey Matthews, Sarah Murray, et al.
Journal of the American College of Cardiology|March 26, 2016
Reply: Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?Robert A Henderson, Chris Jarvis, Tim Clayton, et al.
Journal of the American College of Cardiology|February 6, 2016
Reply: Survival Differences in Clinical Trials With Long-Term Follow-upRobert A Henderson, Chris Jarvis, Tim Clayton, et al.
Science & Justice : Journal of the Forensic Science Society|March 19, 2021
An investigation of two methods of DNA recovery from fired and unfired 9 mm ammunitionDavid Moore, Dan Beaumont, Melanie Brown, et al.
Circulation|July 9, 2008
Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS)Jean Booth, Tim Clayton, John Pepper, et al.
Journal of the American College of Cardiology|October 22, 2013
Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)Gregg W Stone, Tim Clayton, Efthymios N Deliargyris, et al.
BMJ (Clinical Research Ed.)|August 19, 2014
Quantification of risk factors for herpes zoster: population based case-control studyHarriet J Forbes, Krishnan Bhaskaran, Sara L Thomas, et al.
Research Involvement and Engagement|March 9, 2021
Patient and public involvement prior to trial initiation: lessons learnt for rapid partnership in the COVID-19 eraZahra Jamal, Alexander Perkins, Christopher Allen, et al.
Therapeutic Innovation & Regulatory Science|February 26, 2025
The Data Monitoring Experience in Empagliflozin Randomized Clinical Trials Between 2011 and 2024Francine K Welty, Klaus G Parhofer, Marvin Konstam, et al.
Pageof 11